Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPSN - CA2943752097 - Common Stock

4.58 USD
-0.06 (-1.29%)
Last: 1/2/2026, 12:19:07 PM
Fundamental Rating

6

EPSN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 209 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EPSN has a bad growth rate and is valued cheaply. This makes EPSN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EPSN was profitable.
In the past year EPSN had a positive cash flow from operations.
EPSN had positive earnings in each of the past 5 years.
EPSN had a positive operating cash flow in each of the past 5 years.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.66%, EPSN is in the better half of the industry, outperforming 65.07% of the companies in the same industry.
EPSN has a Return On Equity of 5.87%. This is comparable to the rest of the industry: EPSN outperforms 46.89% of its industry peers.
EPSN has a better Return On Invested Capital (7.03%) than 63.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EPSN is significantly below the industry average of 21.27%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

With a decent Profit Margin value of 12.86%, EPSN is doing good in the industry, outperforming 64.59% of the companies in the same industry.
In the last couple of years the Profit Margin of EPSN has declined.
EPSN has a Operating Margin of 29.19%. This is in the better half of the industry: EPSN outperforms 71.29% of its industry peers.
EPSN's Operating Margin has declined in the last couple of years.
EPSN has a Gross Margin of 74.48%. This is amongst the best in the industry. EPSN outperforms 86.12% of its industry peers.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EPSN is still creating some value.
EPSN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EPSN has been reduced compared to 5 years ago.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.96 indicates that EPSN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EPSN (2.96) is better than 83.25% of its industry peers.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.96
ROIC/WACC0.8
WACC8.82%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

EPSN has a Current Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.93, EPSN is doing good in the industry, outperforming 76.08% of the companies in the same industry.
EPSN has a Quick Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.93, EPSN is doing good in the industry, outperforming 78.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.00%, which is quite impressive.
The earnings per share for EPSN have been decreasing by -22.77% on average. This is quite bad
Looking at the last year, EPSN shows a very strong growth in Revenue. The Revenue has grown by 46.76%.
The Revenue has been growing slightly by 3.38% on average over the past years.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.35 indicates a reasonable valuation of EPSN.
Based on the Price/Earnings ratio, EPSN is valued cheaply inside the industry as 83.25% of the companies are valued more expensively.
EPSN is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.35, the valuation of EPSN can be described as very reasonable.
Based on the Price/Forward Earnings ratio, EPSN is valued a bit cheaper than 77.03% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. EPSN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.35
Fwd PE 9.35
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

84.69% of the companies in the same industry are more expensive than EPSN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EPSN is valued a bit cheaper than the industry average as 72.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.2
EV/EBITDA 3.9
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EPSN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.14%, EPSN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.93, EPSN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.00, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.14%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

EPSN pays out 93.55% of its income as dividend. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (1/2/2026, 12:19:07 PM)

4.58

-0.06 (-1.29%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-17 2026-03-17
Inst Owners61.62%
Inst Owner Change-3.95%
Ins Owners6.94%
Ins Owner Change0.82%
Market Cap111.29M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (87.12%)
Short Float %3.42%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield 5.14%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.35
Fwd PE 9.35
P/S 2.43
P/FCF 11.2
P/OCF 4.3
P/B 1.11
P/tB 1.11
EV/EBITDA 3.9
EPS(TTM)0.49
EY10.7%
EPS(NY)0.49
Fwd EY10.69%
FCF(TTM)0.41
FCFY8.93%
OCF(TTM)1.07
OCFY23.28%
SpS1.88
BVpS4.12
TBVpS4.12
PEG (NY)0.05
PEG (5Y)N/A
Graham Number6.74
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 2.96
F-Score7
WACC8.82%
ROIC/WACC0.8
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status for EPSN stock?

ChartMill assigns a valuation rating of 8 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Undervalued.


How profitable is EPSILON ENERGY LTD (EPSN) stock?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 6 / 10.


How financially healthy is EPSILON ENERGY LTD?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 8 / 10.


What is the earnings growth outlook for EPSILON ENERGY LTD?

The Earnings per Share (EPS) of EPSILON ENERGY LTD (EPSN) is expected to grow by 206% in the next year.